244 related articles for article (PubMed ID: 31360295)
1. Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection.
Strycharz-Dudziak M; Kiełczykowska M; Drop B; Świątek Ł; Kliszczewska E; Musik I; Polz-Dacewicz M
Oxid Med Cell Longev; 2019; 2019():5832410. PubMed ID: 31360295
[TBL] [Abstract][Full Text] [Related]
2. Glutathione Peroxidase (GPx) and Superoxide Dismutase (SOD) in Oropharyngeal Cancer Associated with EBV and HPV Coinfection.
Strycharz-Dudziak M; Fołtyn S; Dworzański J; Kiełczykowska M; Malm M; Drop B; Polz-Dacewicz M
Viruses; 2020 Sep; 12(9):. PubMed ID: 32917014
[TBL] [Abstract][Full Text] [Related]
3. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus.
Dworzański J; Strycharz-Dudziak M; Kliszczewska E; Kiełczykowska M; Dworzańska A; Drop B; Polz-Dacewicz M
PLoS One; 2020; 15(3):e0230374. PubMed ID: 32210468
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
6. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
[TBL] [Abstract][Full Text] [Related]
7. Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.
Fołtyn S; Strycharz-Dudziak M; Drop B; Boguszewska A; Polz-Dacewicz M
Infect Agent Cancer; 2017; 12():31. PubMed ID: 28572837
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
10. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
Park Y; Park BG; Ha J; Kim HS
Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
[TBL] [Abstract][Full Text] [Related]
12. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
[TBL] [Abstract][Full Text] [Related]
13. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
14. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
17. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
18. Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein-Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis.
Shahi V; Agarwal P; Qayoom S; Kumar V; Tewari S; Raghuvanshi S; Singh US; Goel MM
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3717-3723. PubMed ID: 36444584
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus in hepatocellular carcinogenesis.
Li W; Wu BA; Zeng YM; Chen GC; Li XX; Chen JT; Guo YW; Li MH; Zeng Y
World J Gastroenterol; 2004 Dec; 10(23):3409-13. PubMed ID: 15526357
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]